CFI has recently written to the Minister for Health to urge once again that the negotiations on Orkambi and the extension of Kalydeco are concluded in a positive way for our members as soon as possible and to remind him and the government of the importance of these drugs to our members.
Background note:
Cystic Fibrosis Ireland has undertaken significant lobbying on this issue including:
We acknowledge and thank patient advocates and parents who have been active on this crucial issue and we will bring you news as soon as we hear the outcome from the negotiations.
Philip Watt
CEO
Cystic Fibrosis Ireland